Literature DB >> 18546598

A protocol for constructing gene targeting vectors: generating knockout mice for the cadherin family and beyond.

Sen Wu1, Guoxin Ying, Qiang Wu, Mario R Capecchi.   

Abstract

We describe here a streamlined procedure for targeting vector construction, which often is a limiting factor for gene targeting (knockout) technology. This procedure combines various highly efficient recombination-based cloning methods in bacteria, consisting of three steps. First step is the use of Red-pathway-mediated recombination (recombineering) to capture a genomic fragment into a Gateway-compatible vector. Second, the vector is modified by recombineering to include a positive selection gene neo, from a variety of modular reagents. Finally, through a simple in vitro Gateway recombination, the modified genomic fragment is switched into a vector that contains negative selection cassettes, as well as unique sites for linearization. To demonstrate the usefulness of this protocol, we report targeted disruptions of members of the cadherin gene family, focusing on those that have not been previously studied at the molecular genetic level. This protocol needs 2 weeks to construct a targeting vector, and several vectors can be easily handled simultaneously using common laboratory setup.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18546598     DOI: 10.1038/nprot.2008.70

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  51 in total

1.  Generating gene knockout rats by homologous recombination in embryonic stem cells.

Authors:  Chang Tong; Guanyi Huang; Charles Ashton; Ping Li; Qi-Long Ying
Journal:  Nat Protoc       Date:  2011-05-26       Impact factor: 13.491

2.  Collecting duct-specific knockout of adenylyl cyclase type VI causes a urinary concentration defect in mice.

Authors:  Karl P Roos; Kevin A Strait; Kalani L Raphael; Mitsi A Blount; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

3.  Transgenic enrichment of mouse embryonic stem cell-derived progenitor motor neurons.

Authors:  Dylan A McCreedy; Cara R Rieger; David I Gottlieb; Shelly E Sakiyama-Elbert
Journal:  Stem Cell Res       Date:  2011-12-13       Impact factor: 2.020

4.  Generation of highly enriched V2a interneurons from mouse embryonic stem cells.

Authors:  Nisha R Iyer; James E Huettner; Jessica C Butts; Chelsea R Brown; Shelly E Sakiyama-Elbert
Journal:  Exp Neurol       Date:  2016-01-16       Impact factor: 5.330

5.  Generation and characterization of a conditional deletion allele for Lmna in mice.

Authors:  Youngjo Kim; Yixian Zheng
Journal:  Biochem Biophys Res Commun       Date:  2013-08-30       Impact factor: 3.575

6.  OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation.

Authors:  Ying Liu; Peng Jiang; Wenbin Deng
Journal:  Nat Protoc       Date:  2011-04-21       Impact factor: 13.491

7.  T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis.

Authors:  Melinda L Angus-Hill; Kathryn M Elbert; Julio Hidalgo; Mario R Capecchi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

8.  Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis.

Authors:  Kristina E Hill; Sen Wu; Amy K Motley; Teri D Stevenson; Virginia P Winfrey; Mario R Capecchi; John F Atkins; Raymond F Burk
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

9.  Deletion of both centrin 2 (CETN2) and CETN3 destabilizes the distal connecting cilium of mouse photoreceptors.

Authors:  Guoxin Ying; Jeanne M Frederick; Wolfgang Baehr
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

10.  Sepp1(UF) forms are N-terminal selenoprotein P truncations that have peroxidase activity when coupled with thioredoxin reductase-1.

Authors:  Suguru Kurokawa; Sofi Eriksson; Kristie L Rose; Sen Wu; Amy K Motley; Salisha Hill; Virginia P Winfrey; W Hayes McDonald; Mario R Capecchi; John F Atkins; Elias S J Arnér; Kristina E Hill; Raymond F Burk
Journal:  Free Radic Biol Med       Date:  2014-01-14       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.